11![DG-GT 2015, preliminary programme (status:00-11:30 11:30.12:00 DG-GT 2015, preliminary programme (status:00-11:30 11:30.12:00](https://www.pdfsearch.io/img/609021c27be2f61870d440b103ed17b9.jpg) | Add to Reading ListSource URL: dg-gt2015.univie.ac.atLanguage: English - Date: 2015-02-23 04:39:12
|
---|
12![This article was downloaded by: [On: 18 December 2014, At: 05:56 Publisher: Taylor & Francis Informa Ltd Registered in England and Wales Registered Number: Registered office: Mortimer House, 37-41 This article was downloaded by: [On: 18 December 2014, At: 05:56 Publisher: Taylor & Francis Informa Ltd Registered in England and Wales Registered Number: Registered office: Mortimer House, 37-41](https://www.pdfsearch.io/img/5e8f587af223729bb909792028262ac0.jpg) | Add to Reading ListSource URL: oncos.comLanguage: English - Date: 2014-12-18 09:23:51
|
---|
13![Enhancing adoptive T-cell therapy with oncolytic adenovirus encoding CD40-ligand Suvi 1,2 Parviainen , Enhancing adoptive T-cell therapy with oncolytic adenovirus encoding CD40-ligand Suvi 1,2 Parviainen ,](https://www.pdfsearch.io/img/871ce856639a23831678ec143b9fb50b.jpg) | Add to Reading ListSource URL: tiltbio.comLanguage: English - Date: 2015-05-18 06:39:56
|
---|
14![Characterization of tumor-infiltrating lymphocytes following intratumoral administration of ONCOS-102 for refractory solid tumor cancer patients Pesonen S1, Hemminki A2, von Euler M1, Vuolanto A1, Backman C1, Hakonen T1, Characterization of tumor-infiltrating lymphocytes following intratumoral administration of ONCOS-102 for refractory solid tumor cancer patients Pesonen S1, Hemminki A2, von Euler M1, Vuolanto A1, Backman C1, Hakonen T1,](https://www.pdfsearch.io/img/4156009ea6ea0e937f395d2bf04733e5.jpg) | Add to Reading ListSource URL: oncos.comLanguage: English - Date: 2014-06-19 02:40:06
|
---|
15![Abscopal effect seen with T-cell therapy enhancing oncolytic adenoviruses armed with TNFα and IL-2 Riikka Havunen1, Suvi Parviainen1,4, Mikko Siurala1,4, Michael Behr1, Dirk Nettelbeck2, Anja Ehrhardt3, Akseli Hemminki1 Abscopal effect seen with T-cell therapy enhancing oncolytic adenoviruses armed with TNFα and IL-2 Riikka Havunen1, Suvi Parviainen1,4, Mikko Siurala1,4, Michael Behr1, Dirk Nettelbeck2, Anja Ehrhardt3, Akseli Hemminki1](https://www.pdfsearch.io/img/bd524bfa44760cbe2201a05cd56ff201.jpg) | Add to Reading ListSource URL: tiltbio.comLanguage: English - Date: 2015-05-19 03:21:16
|
---|
16![Award ID: CP130013 Project Title: Clinical Development and Commercialization of Oncolytic Adenovirus for Treating Malignant Glioma Award Mechanism: Award ID: CP130013 Project Title: Clinical Development and Commercialization of Oncolytic Adenovirus for Treating Malignant Glioma Award Mechanism:](https://www.pdfsearch.io/img/cc49814cac252621eb247055d67042f9.jpg) | Add to Reading ListSource URL: www.cprit.state.tx.usLanguage: English - Date: 2015-03-24 12:30:05
|
---|
17![Oncolytic adenovirus improves anti-tumor efficacy of adoptive T-cell therapy by breaking tumor tolerance Siri Tähtinen1, Susanna Grönberg-Vähä-Koskela1, Dave Lumen3, Maiju Merisalo-Soikkeli1, Mikko Siurala1,2, Anu J. Oncolytic adenovirus improves anti-tumor efficacy of adoptive T-cell therapy by breaking tumor tolerance Siri Tähtinen1, Susanna Grönberg-Vähä-Koskela1, Dave Lumen3, Maiju Merisalo-Soikkeli1, Mikko Siurala1,2, Anu J.](https://www.pdfsearch.io/img/9ef8a058a95b698b53d7e7835e4ca66b.jpg) | Add to Reading ListSource URL: tiltbio.comLanguage: English - Date: 2015-05-18 06:39:50
|
---|
18![Gene Therapy and Molecular Biology Vol 1, page 215 Gene Ther Mol Biol Vol 1, March, 1998. Gene transfer to the nervous system using HSV vectors M. Karina Soares1, William H. Goins1, Joseph C. Glorioso1,2,3, and Gene Therapy and Molecular Biology Vol 1, page 215 Gene Ther Mol Biol Vol 1, March, 1998. Gene transfer to the nervous system using HSV vectors M. Karina Soares1, William H. Goins1, Joseph C. Glorioso1,2,3, and](https://www.pdfsearch.io/img/3765060c9618cf3cb43bc051707bb818.jpg) | Add to Reading ListSource URL: www.gtmb.orgLanguage: English - Date: 2013-06-22 08:37:06
|
---|
19![FINAL FOR DISTRIBUTION PSIOXUS THERAPEUTICS RAISES A £25M SERIES C INVESTMENT TO PROGRESS ONCOLYTIC VIRUS PLUS CHECKPOINT INHIBITOR COMBINATION STUDY IN METASTATIC COLORECTAL CANCER OXFORD, UK – 19 May 2015 – PsiOxu FINAL FOR DISTRIBUTION PSIOXUS THERAPEUTICS RAISES A £25M SERIES C INVESTMENT TO PROGRESS ONCOLYTIC VIRUS PLUS CHECKPOINT INHIBITOR COMBINATION STUDY IN METASTATIC COLORECTAL CANCER OXFORD, UK – 19 May 2015 – PsiOxu](https://www.pdfsearch.io/img/b003540f29815e169ace73d501e0bdb0.jpg) | Add to Reading ListSource URL: www.psioxus.comLanguage: English - Date: 2015-05-19 03:49:40
|
---|
20![Repeated intratumoral administration of ONCOS-102 leads to robust cellular and transcriptional immune activation at tumor site in an ovarian cancer patient Vassilev L.1, Hemminki A.2, Joensuu T.3, Jäger E.4, Karbach J.4 Repeated intratumoral administration of ONCOS-102 leads to robust cellular and transcriptional immune activation at tumor site in an ovarian cancer patient Vassilev L.1, Hemminki A.2, Joensuu T.3, Jäger E.4, Karbach J.4](https://www.pdfsearch.io/img/dccd580c781b67f6ff4b62706ace628e.jpg) | Add to Reading ListSource URL: oncos.comLanguage: English - Date: 2014-07-10 04:16:00
|
---|